Hinge Health (HNGE) Research & Development (2024 - 2026)

Hinge Health's Research & Development history runs 3 years deep, the most recent figure standing at $30.3 million for Q1 2026.

• In Q1 2026, Research & Development rose 29.1% year-over-year to $30.3 million; the TTM figure through Mar 2026 stood at $375.0 million (up 296.49% YoY), while the FY2025 annual figure was $368.1 million, up 265.07% from the prior year.
• Research & Development came in at $30.3 million for Q1 2026 at Hinge Health, down from $32.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $280.0 million in Q2 2025 to a low of $22.4 million in Q4 2024.
• A 3-year average of $58.7 million and a median of $27.6 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 1023.44% in 2025 and grew 29.1% in 2026, its largest moves.
• Hinge Health's Research & Development stood at $22.4 million in 2024, then soared by 46.42% to $32.8 million in 2025, then retreated by 7.38% to $30.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $30.3 million, $32.8 million, and $31.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison